納布里瓦治療公司
US ˙ OTCPK

簡介

本頁面提供了有關 Colin MD Broom 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Colin MD Broom已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:NBRV / Nabriva Therapeutics Plc Director 36,523
Chief Executive Officer, Director 261,000
US:NPSP / NPS Pharmaceuticals Inc Director 0
US:VPHM / Shire Viropharma Inc VP & Chief Scientific Officer 0
如何解讀這些圖表

以下圖表顯示了在Colin MD Broom進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

NBRVF / Nabriva Therapeutics plc內部人士買入 - 短期收益分析

在這一部分,我們分析了在 NBRVF / Nabriva Therapeutics plc 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2019-08-30 NBRV Broom Colin MD 10,177 2.0309 582 35.5407 20,668 14 645 354,077 1,713.17
2018-06-22 NBRV Broom Colin MD 5,000 3.7200 286 65.1000 18,600
2018-05-23 NBRV Broom Colin MD 10,000 4.6000 571 80.5000 46,000
2017-09-22 NBRV Broom Colin MD 2,588 8.3500 148 146.1250 21,610

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

NBRVF / Nabriva Therapeutics plc Insider Trades
NBRVF / Nabriva Therapeutics plc內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 NBRVF / Nabriva Therapeutics plc 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2022-08-02 NBRV Broom Colin MD 5,339 0.1902 214 4.7550 1,015 157 1.3000 -738 -72.72
2021-08-02 NBRV Broom Colin MD 531 1.2000 21 30.0000 637
2020-08-20 NBRV Broom Colin MD 11,064 0.6476 632 11.3330 7,165
2019-08-21 NBRV Broom Colin MD 10,177 2.0700 582 36.2250 21,066

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

NBRVF / Nabriva Therapeutics plc Insider Trades
歷史內部人交易

該表格顯示了由 Colin MD Broom 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2022-08-04 2022-08-02 4 NBRV Nabriva Therapeutics plc
Ordinary Shares
S - Sale -5,339 36,523 -12.75 0.19 -1,015 6,947
2021-08-04 2021-08-02 4 NBRV Nabriva Therapeutics plc
Ordinary Shares
S - Sale -531 41,862 -1.25 1.20 -637 50,234
2021-07-30 2021-07-28 4 NBRV Nabriva Therapeutics plc
Share Options
A - Award 35,000 35,000
2021-07-30 2021-07-28 4 NBRV Nabriva Therapeutics plc
Ordinary Shares
A - Award 17,500 42,393 70.30
2020-08-21 2020-08-20 4 NBRV Nabriva Therapeutics plc
Ordinary Shares
S - Sale -11,064 248,936 -4.26 0.65 -7,165 161,211
2020-08-21 2020-08-19 4 NBRV Nabriva Therapeutics plc
Restricted Share Units
M - Exercise -33,750 0 -100.00
2020-08-21 2020-08-19 4 NBRV Nabriva Therapeutics plc
Ordinary Shares
M - Exercise 33,750 260,000 14.92
2020-07-31 2020-07-29 4 NBRV Nabriva Therapeutics plc
Stock Options
A - Award 35,000 35,000
2020-07-31 2020-07-29 4 NBRV Nabriva Therapeutics plc
Ordinary Shares
A - Award 17,500 226,250 8.38
2019-09-03 2019-08-30 4 NBRV Nabriva Therapeutics plc
Ordinary Shares
P - Purchase 10,177 208,750 5.13 2.03 20,668 423,950
2019-08-26 2019-08-21 4/A NBRV Nabriva Therapeutics plc
Ordinary Shares
S - Sale -10,177 125,724 -7.49 2.07 -21,066 260,249
2019-08-21 2019-08-21 4 NBRV Nabriva Therapeutics plc
Ordinary Shares
F - Taxes -10,177 125,724 -7.49 2.07 -21,066 260,249
2019-08-21 2019-08-19 4 NBRV Nabriva Therapeutics plc
Restricted Share Units
M - Exercise -33,750 33,750 -50.00
2019-08-21 2019-08-19 4 NBRV Nabriva Therapeutics plc
Ordinary Shares
M - Exercise 33,750 135,901 33.04
2019-08-01 2019-07-31 4 NBRV Nabriva Therapeutics plc
Stock Option
A - Award 35,000 35,000
2018-06-25 2018-06-22 4 NBRV Nabriva Therapeutics plc
Ordinary Shares
P - Purchase 5,000 102,151 5.15 3.72 18,600 380,002
2018-05-23 2018-05-23 4 NBRV Nabriva Therapeutics plc
Ordinary Shares F1
P - Purchase 10,000 97,151 11.47 4.60 46,000 446,895
2018-02-02 2018-01-31 4 NBRV Nabriva Therapeutics plc
Restricted Stock Units
A - Award 67,500 67,500
2018-02-02 2018-01-31 4 NBRV Nabriva Therapeutics plc
Stock Options
A - Award 200,000 200,000
2017-09-26 2017-09-22 4 NBRV Nabriva Therapeutics plc
Ordinary Shares
P - Purchase 2,588 87,151 3.06 8.35 21,610 727,711
2017-06-27 2017-06-23 4 NBRV Nabriva Therapeutics Plc
Stock Option
J - Other 261,000 261,000
2017-06-27 2017-06-23 4 NBRV Nabriva Therapeutics Plc
Stock Option
J - Other 151,000 151,000
2017-06-27 2017-06-23 4 NBRV Nabriva Therapeutics Plc
Stock Option
J - Other 196,900 196,900
2017-06-27 2017-06-23 4 NBRV Nabriva Therapeutics Plc
Stock Option
J - Other 158,270 158,270
2017-06-27 2017-06-23 4 NBRV Nabriva Therapeutics Plc
Ordinary Shares
J - Other 155,817 155,817
2017-06-27 2017-06-23 4 NBRV Nabriva Therapeutics Plc
Ordinary Shares
J - Other 1,595 1,595
2017-02-09 2017-02-07 4 NBRV Nabriva Therapeutics AG
Stock Option
A - Award 26,100 26,100
2016-12-30 3 NBRV Nabriva Therapeutics AG
Common Shares
15,900
2016-12-30 3 NBRV Nabriva Therapeutics AG
Common Shares
31,323
2016-12-30 3 NBRV Nabriva Therapeutics AG
Common Shares
15,900
2016-12-30 3 NBRV Nabriva Therapeutics AG
Common Shares
31,323
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Deferred Stock Units
D - Sale to Issuer -29,759 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -3,816 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options (right to buy)
D - Sale to Issuer -36,000 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
U - Other -24,313 0 -100.00 46.00 -1,118,398
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 3,816 3,816
2014-02-14 2014-02-13 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -15,188 0 -100.00
2014-02-14 2014-02-13 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 15,188 24,313 166.44
2014-02-14 2014-02-12 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 4,572 4,572
2014-01-28 2014-01-24 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -40,000 0 -100.00
2014-01-28 2014-01-24 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -32,516 0 -100.00
2014-01-28 2014-01-24 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -34,570 0 -100.00
2014-01-28 2014-01-24 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -35,723 0 -100.00
2014-01-28 2014-01-24 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -27,265 0 -100.00
2014-01-28 2014-01-24 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -40,261 0 -100.00
2014-01-28 2014-01-24 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -40,261 0 -100.00
2014-01-28 2014-01-24 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -50,000 0 -100.00
2014-01-28 2014-01-24 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -36,920 0 -100.00
2014-01-28 2014-01-24 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -52,593 0 -100.00
2014-01-28 2014-01-24 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -49,975 0 -100.00
2014-01-28 2014-01-24 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -33,439 0 -100.00
2014-01-28 2014-01-24 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -34,932 0 -100.00
2014-01-28 2014-01-24 4 VPHM VIROPHARMA INC
Common Stock
D - Sale to Issuer -48,878 0 -100.00
2014-01-28 2014-01-24 4 VPHM VIROPHARMA INC
Common Stock
A - Award 48,878 48,878
2014-01-28 2014-01-24 4 VPHM VIROPHARMA INC
Common Stock
U - Other -154,058 0 -100.00 50.00 -7,702,900
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
M - Exercise -5,068 34,932 -12.67
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
M - Exercise -6,561 33,439 -16.40
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
M - Exercise -7,407 52,593 -12.34
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
M - Exercise -5,025 49,975 -9.14
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
M - Exercise -5,001 0 -100.00
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
M - Exercise -13,080 36,920 -26.16
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
M - Exercise -10,000 0 -100.00
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Incentive Stock Option (Right to Buy)
M - Exercise -90,000 30,000 -75.00
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Common Stock
F - Taxes -2,134 154,058 -1.37 49.80 -106,273 7,672,088
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Common Stock
M - Exercise 5,068 156,192 3.35 19.73 99,992 3,081,668
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Common Stock
F - Taxes -2,196 151,124 -1.43 49.80 -109,361 7,525,975
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Common Stock
M - Exercise 6,561 153,320 4.47 15.24 99,990 2,336,597
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Common Stock
F - Taxes -2,231 146,759 -1.50 49.80 -111,104 7,308,598
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Common Stock
M - Exercise 7,407 148,990 5.23 13.50 99,994 2,011,365
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Common Stock
F - Taxes -1,175 141,583 -0.82 49.80 -58,515 7,050,833
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Common Stock
M - Exercise 5,025 142,758 3.65 9.99 50,200 1,426,152
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Common Stock
F - Taxes -1,166 137,733 -0.84 49.80 -58,067 6,859,103
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Common Stock
M - Exercise 5,001 138,899 3.73 9.96 49,810 1,383,434
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Common Stock
F - Taxes -2,773 133,898 -2.03 49.80 -138,095 6,668,120
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Common Stock
M - Exercise 13,080 136,671 10.58 8.86 115,889 1,210,905
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Common Stock
F - Taxes -1,551 123,591 -1.24 49.80 -77,240 6,154,832
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Common Stock
M - Exercise 10,000 125,142 8.68 5.91 59,100 739,589
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Common Stock
F - Taxes -6,914 115,142 -5.66 49.80 -344,317 5,734,072
2014-01-10 2014-01-08 4 VPHM VIROPHARMA INC
Common Stock
M - Exercise 90,000 122,056 280.76 1.84 165,600 224,583
2013-06-12 2013-06-10 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
A - Award 32,516 32,516
2013-02-15 2013-02-13 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 15,188 15,188
2013-02-11 2013-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common stock
S - Sale X -6,100 9,125 -40.07 8.74 -53,314 79,752
2013-02-11 2013-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common stock
J - Other 15,225 15,225
2013-01-07 2013-01-03 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
A - Award 34,570 34,570
2012-12-28 2012-12-27 4 VPHM VIROPHARMA INC
Incentive Stock Option (Right to Buy)
M - Exercise -10,000 120,000 -7.69
2012-12-28 2012-12-27 4 VPHM VIROPHARMA INC
Common Stock
M - Exercise X 10,000 30,167 49.59 1.84 18,400 55,507
2012-12-28 2012-12-24 4/A VPHM VIROPHARMA INC
Common Stock
S - Sale X -17,500 20,167 -46.46 22.53 -394,301 454,393
2012-12-27 2012-12-24 4 VPHM VIROPHARMA INC
Incentive Stock Option (Right to Buy)
M - Exercise -17,500 112,500 -13.46
2012-12-27 2012-12-24 4 VPHM VIROPHARMA INC
Common Stock
S - Sale X -17,500 37,667 -31.72 22.53 -394,301 848,694
2012-12-27 2012-12-24 4 VPHM VIROPHARMA INC
Common Stock
M - Exercise 17,500 55,167 46.46 1.84 32,200 101,507
2012-12-12 2012-12-10 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
M - Exercise -14,999 5,001 -75.00
2012-12-12 2012-12-10 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
M - Exercise -50,000 50,000 -50.00
2012-12-12 2012-12-10 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
M - Exercise -10,000 10,000 -50.00
2012-12-12 2012-12-10 4 VPHM VIROPHARMA INC
Common Stock
S - Sale -14,999 37,667 -28.48 24.07 -360,984 906,539
2012-12-12 2012-12-10 4 VPHM VIROPHARMA INC
Common Stock
M - Exercise 14,999 52,666 39.82 9.96 149,390 524,553
2012-12-12 2012-12-10 4 VPHM VIROPHARMA INC
Common Stock
S - Sale -50,000 37,667 -57.03 24.07 -1,203,360 906,539
2012-12-12 2012-12-10 4 VPHM VIROPHARMA INC
Common Stock
M - Exercise 50,000 87,667 132.74 8.86 443,000 776,730
2012-12-12 2012-12-10 4 VPHM VIROPHARMA INC
Common Stock
S - Sale -10,000 37,667 -20.98 24.07 -240,672 906,539
2012-12-12 2012-12-10 4 VPHM VIROPHARMA INC
Common Stock
M - Exercise 10,000 47,667 26.55 5.91 59,100 281,712
2012-06-06 2012-06-04 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
A - Award 35,723 35,723
2012-05-23 2012-05-16 4 NPSP NPS PHARMACEUTICALS INC
Deferred Stock Units
A - Award 403 29,759 1.37
2012-02-09 2012-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
A - Award 15,225 15,225
2012-01-19 2012-01-17 4 NPSP NPS PHARMACEUTICALS INC
Deferred Stock Units
A - Award 2,278 29,356 8.41
2012-01-06 2012-01-05 4 VPHM VIROPHARMA INC
Employee Stock Option (Right to Buy)
A - Award 27,265 27,265
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)